NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Herriot TabuteauChief Executive Officer2025-12-0410,558$148.18
$1.56MSell
Herriot TabuteauChief Executive Officer2025-12-0410,558$8.02
$84.68kBuy
Herriot TabuteauChief Executive Officer2025-12-0320,163$146.94
$2.96MSell
Herriot TabuteauChief Executive Officer2025-12-0320,163$8.02
$161.71kBuy
Herriot TabuteauChief Executive Officer2025-12-0249,252$144.59
$7.12MSell
Herriot TabuteauChief Executive Officer2025-12-0249,252$8.02
$395.00kBuy
Herriot TabuteauChief Executive Officer2025-11-0521,775$134.49
$2.93MSell
Herriot TabuteauChief Executive Officer2025-11-0521,775$8.02
$174.64kBuy
Herriot TabuteauChief Executive Officer2025-11-0450,459$8.02
$404.68kBuy
Herriot TabuteauChief Executive Officer2025-11-0450,459$133.79
$6.75MSell

1 of 7

AXSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau29.15%14,696,229$2.26BInsider
Antecip Capital LLC14.57%7,344,500$1.13BInsider
Vanguard Group Inc8.29%4,180,646$642.31MInstitution
Blackrock Inc7.52%3,790,929$582.44MInstitution
Wellington Management Group LLP2.65%1,334,560$205.04MInstitution
Rtw Investments LP2.22%1,118,883$171.91MInstitution
Macquarie Group Ltd2.15%1,084,536$166.63MInstitution
Price T Rowe Associates Inc2.06%1,037,448$159.39MInstitution
Geode Capital Management LLC1.98%997,700$153.29MInstitution
Invesco Ltd1.96%990,557$152.19MInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM61.71%38.29%Net SellingNet Buying
CYTK90.23%9.77%Net SellingNet Selling
NUVL75.78%24.22%Net SellingNet Selling
MRUS31.37%68.63%Net BuyingNet Buying
RYTM98.14%1.86%Net SellingNet Buying

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 73.75% institutional shareholders, 45.75% Axsome Therapeutics insiders, and 0.00% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 14.70M shares representing 29.15% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $2.23B.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.